CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80

CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 was reported 555 times

CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AQUEOUS MISDIRECTION 1 0.3333
1 OESOPHAGEAL MANOMETRY 1 0.2500
2 TEAR FILM INSTABILITY 1 0.1000
3 ANNULAR PANCREAS 1 0.0833
4 LENS CAPSULOTOMY 1 0.0769
5 DACRYOCYSTORHINOSTOMY 1 0.0400
6 AMNIOTIC MEMBRANE GRAFT 1 0.0385
7 IRIDOTOMY 1 0.0333
8 EYE ABRASION 1 0.0189
9 KERATOMILEUSIS 4 0.0156
10 ANISOMETROPIA 1 0.0154
11 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 1 0.0125
12 LIMBAL STEM CELL DEFICIENCY 1 0.0122
13 INTRAOCULAR LENS IMPLANT 6 0.0121
14 PERIORBITAL PAIN 10 0.0118
15 EYELID OPERATION 3 0.0112
16 MEIBOMIAN GLAND DYSFUNCTION 5 0.0110
17 PHARYNGO-OESOPHAGEAL DIVERTICULUM 1 0.0110
18 EYE OPACITY 1 0.0109
19 EYE INFARCTION 1 0.0100
20 PRODUCT PRIMARY PACKAGING ISSUE 1 0.0089
21 KERATORHEXIS 1 0.0088
22 GLAUCOMA SURGERY 2 0.0078
23 NEUROLOGICAL PROCEDURAL COMPLICATION 1 0.0076
24 ENTROPION 1 0.0065
25 EYE PARAESTHESIA 1 0.0064
26 EYELID PAIN 11 0.0054
27 LIGHT CHAIN ANALYSIS ABNORMAL 1 0.0048
28 CENTRAL VISION LOSS 1 0.0045
29 JEJUNAL PERFORATION 1 0.0041
30 CORNEAL DEGENERATION 1 0.0041
31 GLARE 2 0.0039
32 INJURY CORNEAL 2 0.0038
33 RETINITIS PIGMENTOSA 1 0.0038
34 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
35 CHEMICAL BURNS OF EYE 1 0.0036
36 RETINAL OPERATION 1 0.0036
37 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
38 OCULAR SURFACE DISEASE 1 0.0036
39 EYELID THICKENING 1 0.0035
40 POSITIVE AIRWAY PRESSURE THERAPY 1 0.0034
41 EYE OPERATION 15 0.0033
42 EYELID IRRITATION 8 0.0032
43 SKIN OPERATION 1 0.0032
44 EYELID MARGIN CRUSTING 9 0.0031
45 MITRAL VALVE REPAIR 1 0.0031
46 MACULAR DEGENERATION 37 0.0031
47 NEPHROSTOMY 1 0.0030
48 ALLERGIC RESPIRATORY SYMPTOM 1 0.0030
49 ECTROPION 1 0.0030
50 ACQUIRED OESOPHAGEAL WEB 1 0.0029
51 CONJUNCTIVITIS BACTERIAL 1 0.0029
52 NASAL OPERATION 2 0.0029
53 PTERYGIUM 1 0.0029
54 IDIOPATHIC INTERSTITIAL PNEUMONIA 1 0.0028
55 HYPERPARATHYROIDISM PRIMARY 1 0.0027
56 CORNEAL DISORDER 6 0.0027
57 DRY AGE-RELATED MACULAR DEGENERATION 3 0.0027
58 CORNEAL TRANSPLANT 2 0.0026
59 MULTIPLE USE OF SINGLE-USE PRODUCT 14 0.0025
60 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 1 0.0025
61 MANUFACTURING MATERIALS ISSUE 1 0.0025
62 VAGINAL ULCERATION 1 0.0024
63 PANCREATIC ATROPHY 1 0.0023
64 EYELID INFECTION 1 0.0023
65 REFLUX LARYNGITIS 1 0.0023
66 VULVOVAGINAL RASH 1 0.0023
67 FOREIGN BODY SENSATION IN EYES 14 0.0022
68 CORNEAL ABRASION 3 0.0022
69 ASTHENOPIA 12 0.0022
70 EYE PAIN 122 0.0022
71 LACRIMATION DECREASED 1 0.0021
72 BLOOD CHOLESTEROL 1 0.0021
73 CATARACT 125 0.0021
74 PRODUCT AFTER TASTE 2 0.0021
75 SWELLING OF EYELID 13 0.0021
76 LIQUID PRODUCT PHYSICAL ISSUE 15 0.0021
77 BLADDER MASS 1 0.0020
78 CATARACT OPERATION COMPLICATION 1 0.0020
79 INTERVERTEBRAL DISC DISPLACEMENT 1 0.0019
80 INSTILLATION SITE ERYTHEMA 1 0.0019
81 PRODUCT CONTAINER ISSUE 16 0.0019
82 ABNORMAL SENSATION IN EYE 8 0.0019
83 PRODUCT CLOSURE ISSUE 1 0.0018
84 NAIL INJURY 1 0.0018
85 PRURITUS ALLERGIC 2 0.0017
86 EYE LASER SURGERY 1 0.0017
87 CYANOPSIA 1 0.0017
88 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 1 0.0016
89 OPEN ANGLE GLAUCOMA 1 0.0016
90 PHOTOPHOBIA 30 0.0016
91 CHALAZION 1 0.0016
92 DACRYOSTENOSIS ACQUIRED 2 0.0015
93 EYE DISCHARGE 16 0.0015
94 PRECANCEROUS CONDITION 1 0.0015
95 MACULAR FIBROSIS 1 0.0015
96 DEVICE ELECTRICAL FINDING 1 0.0014
97 EYE IRRITATION 80 0.0014
98 OCULAR DISCOMFORT 15 0.0013
99 BRONCHITIS BACTERIAL 1 0.0013
100 EYE ALLERGY 2 0.0013
101 EYELID EXFOLIATION 1 0.0013
102 EYELID FUNCTION DISORDER 1 0.0013
103 GROWTH OF EYELASHES 1 0.0013
104 PRODUCT CONFUSION 1 0.0013
105 THYROID HORMONES DECREASED 1 0.0013
106 CERUMEN IMPACTION 1 0.0011
107 PUNCTATE KERATITIS 1 0.0011
108 COLOUR BLINDNESS 1 0.0011
109 WRIST SURGERY 1 0.0011
110 CATHETER SITE SWELLING 1 0.0011
111 FOREIGN BODY IN EYE 1 0.0010
112 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
113 DRY EYE 51 0.0010
114 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
115 EYE INJURY 3 0.0010
116 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
117 CONJUNCTIVAL OEDEMA 1 0.0010
118 GALLBLADDER ENLARGEMENT 1 0.0009
119 ERYTHEMA OF EYELID 5 0.0009
120 INSTILLATION SITE REACTION 1 0.0009
121 PRODUCT NAME CONFUSION 1 0.0009
122 SUPERFICIAL INJURY OF EYE 1 0.0009
123 OCULAR HYPERAEMIA 43 0.0009
124 PRODUCT LOT NUMBER ISSUE 2 0.0009
125 CORNEAL OEDEMA 2 0.0009
126 HALO VISION 1 0.0009
127 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
128 EYELID DISORDER 2 0.0009
129 SURGICAL FAILURE 1 0.0009
130 INSTILLATION SITE IRRITATION 1 0.0008
131 EYELID SKIN DRYNESS 1 0.0008
132 RETINAL TEAR 2 0.0008
133 EYE INFECTION 9 0.0008
134 EYE SWELLING 29 0.0008
135 PRODUCT COLOUR ISSUE 4 0.0008
136 LACRIMATION INCREASED 23 0.0008
137 HERPES OPHTHALMIC 1 0.0008
138 PRODUCT DELIVERY MECHANISM ISSUE 4 0.0007
139 PRODUCT LABEL ISSUE 5 0.0007
140 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1 0.0007
141 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
142 BLINDNESS UNILATERAL 10 0.0007
143 AUDITORY DISORDER 1 0.0007
144 HORDEOLUM 3 0.0007
145 STRABISMUS 2 0.0007
146 MENTAL FATIGUE 1 0.0007
147 ASTIGMATISM 1 0.0007
148 AGE-RELATED MACULAR DEGENERATION 1 0.0007
149 PRODUCT DEPOSIT 1 0.0006
150 MEDICAL DEVICE IMPLANTATION 1 0.0006
151 NIGHT BLINDNESS 1 0.0006
152 MEDICAL PROCEDURE 1 0.0006
153 VEIN RUPTURE 1 0.0006
154 EYE DISORDER 19 0.0006
155 PRODUCT USE COMPLAINT 9 0.0006
156 INFUSION SITE DISCHARGE 1 0.0006
157 PANCREATIC FAILURE 1 0.0006
158 ESSENTIAL HYPERTENSION 1 0.0005
159 RETINAL DETACHMENT 5 0.0005
160 BLINDNESS TRANSIENT 4 0.0005
161 AURA 1 0.0005
162 EYE PRURITUS 18 0.0005
163 FACE INJURY 2 0.0005
164 EYE INFLAMMATION 5 0.0005
165 RETINAL OEDEMA 1 0.0005
166 GLAUCOMA 10 0.0005
167 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
168 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
169 BLEPHARITIS 2 0.0005
170 EXOPHTHALMOS 1 0.0005
171 INFUSION SITE BRUISING 1 0.0005
172 FACIAL PAIN 4 0.0004
173 VISION BLURRED 61 0.0004
174 PRODUCT PACKAGING CONFUSION 1 0.0004
175 BRONCHITIS CHRONIC 1 0.0004
176 PRODUCT ADMINISTRATION ERROR 8 0.0004
177 MENOPAUSE 1 0.0004
178 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
179 NASAL DISORDER 1 0.0004
180 MIGRAINE WITH AURA 1 0.0004
181 RENAL CANCER STAGE IV 1 0.0004
182 RHINALGIA 1 0.0004
183 PHARYNGEAL DISORDER 1 0.0003
184 BILIARY COLIC 1 0.0003
185 DEVICE POWER SOURCE ISSUE 1 0.0003
186 KERATITIS 1 0.0003
187 EYELIDS PRURITUS 1 0.0003
188 DEAFNESS NEUROSENSORY 1 0.0003
189 EYE HAEMORRHAGE 4 0.0003
190 WRONG PRODUCT ADMINISTERED 2 0.0003
191 BLINDNESS 12 0.0003
192 PRODUCT ODOUR ABNORMAL 3 0.0003
193 DEVICE USE ISSUE 5 0.0003
194 MACULOPATHY 1 0.0003
195 WOUND HAEMORRHAGE 1 0.0003
196 CHEMOTHERAPY 1 0.0003
197 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
198 COVID-19 PNEUMONIA 3 0.0003
199 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
200 NASAL DISCOMFORT 2 0.0003
201 VISUAL IMPAIRMENT 31 0.0002
202 PERIPHERAL VENOUS DISEASE 1 0.0002
203 PURULENT DISCHARGE 1 0.0002
204 PRODUCT DISPENSING ISSUE 1 0.0002
205 DEVICE OPERATIONAL ISSUE 1 0.0002
206 DIVERTICULUM INTESTINAL 1 0.0002
207 PHYSICAL DISABILITY 1 0.0002
208 RHINITIS ALLERGIC 1 0.0002
209 UVEITIS 3 0.0002
210 ROSACEA 1 0.0002
211 PRODUCT PACKAGING ISSUE 2 0.0002
212 VITREOUS FLOATERS 2 0.0002
213 KNEE OPERATION 2 0.0002
214 FOOT OPERATION 1 0.0002
215 ANEURYSM 1 0.0002
216 HEPATIC ENZYME ABNORMAL 1 0.0002
217 THERAPY PARTIAL RESPONDER 3 0.0002
218 PRODUCT RESIDUE PRESENT 1 0.0002
219 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
220 EXPIRED PRODUCT ADMINISTERED 6 0.0002
221 SNEEZING 4 0.0002
222 PERIORBITAL SWELLING 1 0.0002
223 MOUTH SWELLING 1 0.0002
224 CATARACT OPERATION 1 0.0002
225 MENISCUS INJURY 1 0.0002
226 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
227 CONJUNCTIVITIS 3 0.0002
228 NASAL DRYNESS 1 0.0002
229 DIPLOPIA 4 0.0002
230 HERPES SIMPLEX 1 0.0002
231 SURGERY 9 0.0002
232 HYPOGAMMAGLOBULINAEMIA 1 0.0002
233 WALKING AID USER 1 0.0002
234 PRODUCT FORMULATION ISSUE 1 0.0002
235 ADVERSE REACTION 2 0.0002
236 IMPAIRED GASTRIC EMPTYING 2 0.0001
237 ABNORMAL LOSS OF WEIGHT 1 0.0001
238 EYE MOVEMENT DISORDER 1 0.0001
239 LARGE INTESTINE POLYP 1 0.0001
240 APHONIA 2 0.0001
241 CARPAL TUNNEL SYNDROME 2 0.0001
242 THERMAL BURN 1 0.0001
243 RETINAL HAEMORRHAGE 1 0.0001
244 INTENTIONAL DOSE OMISSION 4 0.0001
245 GRAFT VERSUS HOST DISEASE 1 0.0001
246 VISUAL FIELD DEFECT 1 0.0001
247 PRODUCT STORAGE ERROR 12 0.0001
248 ACCIDENTAL OVERDOSE 5 0.0001
249 KETOACIDOSIS 1 0.0001
250 OSTEOPENIA 2 0.0001
251 THERAPY INTERRUPTED 9 0.0001
252 RHINITIS 1 0.0001
253 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
254 VITAMIN D DECREASED 1 0.0001
255 EXPOSURE VIA SKIN CONTACT 3 0.0001
256 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
257 GASTROINTESTINAL INFECTION 1 0.0001
258 RHINORRHOEA 7 0.0001
259 BREAST CANCER STAGE I 1 0.0001
260 PRODUCT DISTRIBUTION ISSUE 1 0.0001
261 LEUKAEMIA 1 0.0001
262 HYPERCHOLESTEROLAEMIA 1 0.0001
263 EAR PAIN 2 0.0001
264 KIDNEY INFECTION 2 0.0001
265 ARTHRITIS 8 0.0001
266 HOSPICE CARE 1 0.0001
267 DISABILITY 2 0.0001
268 SINUS DISORDER 2 0.0001
269 TOOTH ABSCESS 1 0.0001
270 EAR DISCOMFORT 1 0.0001
271 KNEE ARTHROPLASTY 2 0.0001
272 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
273 ASPIRATION 1 0.0001
274 NERVE INJURY 1 0.0001
275 NEOPLASM MALIGNANT 6 0.0001
276 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
277 IMPAIRED DRIVING ABILITY 1 0.0001
278 ACCIDENT 1 0.0001
279 WRIST FRACTURE 1 0.0001
280 NOCTURIA 1 0.0001
281 PRODUCT DOSE OMISSION ISSUE 24 0.0001
282 SPINAL OPERATION 1 0.0001
283 CYST 1 0.0001
284 MYDRIASIS 1 0.0001
285 HIATUS HERNIA 1 0.0001
286 LIMB INJURY 2 0.0001
287 CORONARY ARTERY OCCLUSION 1 0.0001
288 PERIPHERAL COLDNESS 1 0.0001
289 DIVERTICULITIS 2 0.0001
290 SEASONAL ALLERGY 1 0.0001
291 HYPOACUSIS 3 0.0001
292 IMPAIRED QUALITY OF LIFE 1 0.0001
293 PARAESTHESIA ORAL 1 0.0001
294 DYSSTASIA 2 0.0001
295 CARDIOMYOPATHY 1 0.0001
296 PRODUCT QUALITY ISSUE 9 0.0001
297 ECONOMIC PROBLEM 1 0.0001
298 INSURANCE ISSUE 1 0.0001
299 HYPERSENSITIVITY 12 0.0001
300 TENDONITIS 1 0.0001
301 BASAL CELL CARCINOMA 1 0.0001
302 MIGRAINE 6 0.0001
303 BLOOD POTASSIUM INCREASED 1 0.0001
304 SWELLING FACE 4 0.0001
305 IMPAIRED HEALING 2 0.0001
306 PHOTOSENSITIVITY REACTION 1 0.0001
307 VIRAL INFECTION 2 0.0001
308 FUNGAL INFECTION 2 0.0001
309 PERICARDITIS 1 0.0001
310 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
311 INTENTIONAL PRODUCT MISUSE 5 0.0001
312 BURNING SENSATION 4 0.0001
313 HEAD DISCOMFORT 1 0.0001
314 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
315 RESTLESS LEGS SYNDROME 1 0.0001
316 DYSGEUSIA 4 0.0001
317 FRACTURE 1 0.0001
318 FOOT FRACTURE 1 0.0001
319 BLOOD URINE PRESENT 1 0.0001
320 PULMONARY FIBROSIS 1 0.0001
321 COVID-19 9 0.0001
322 HAEMORRHOIDS 1 0.0001
323 SKIN FISSURES 1 0.0001
324 BLOOD PRESSURE ABNORMAL 1 0.0001
325 UPPER LIMB FRACTURE 1 0.0001
326 FULL BLOOD COUNT DECREASED 1 0.0000
327 FEEDING DISORDER 1 0.0000
328 DISCOMFORT 3 0.0000
329 RIB FRACTURE 1 0.0000
330 ILLNESS 5 0.0000
331 OSTEOARTHRITIS 2 0.0000
332 OFF LABEL USE 40 0.0000
333 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
334 PANCREATITIS ACUTE 1 0.0000
335 CHROMATURIA 1 0.0000
336 MUSCLE TWITCHING 1 0.0000
337 SLEEP DISORDER 3 0.0000
338 INJECTION SITE URTICARIA 1 0.0000
339 AGEUSIA 1 0.0000
340 GASTRIC CANCER 1 0.0000
341 PRODUCT COMPLAINT 1 0.0000
342 EAR INFECTION 1 0.0000
343 BLOOD BILIRUBIN INCREASED 1 0.0000
344 PROCEDURAL PAIN 1 0.0000
345 DEMENTIA 1 0.0000
346 WOUND 1 0.0000
347 OXYGEN SATURATION DECREASED 2 0.0000
348 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
349 RED BLOOD CELL COUNT DECREASED 1 0.0000
350 BALANCE DISORDER 3 0.0000
351 PANCREATIC CARCINOMA 1 0.0000
352 INFECTION 5 0.0000
353 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
354 URINARY INCONTINENCE 1 0.0000
355 HEADACHE 21 0.0000
356 BLOOD POTASSIUM DECREASED 1 0.0000
357 APHASIA 1 0.0000
358 THERAPEUTIC RESPONSE DECREASED 2 0.0000
359 VERTIGO 2 0.0000
360 OROPHARYNGEAL PAIN 3 0.0000
361 BONE DENSITY DECREASED 1 0.0000
362 MOVEMENT DISORDER 1 0.0000
363 HIP FRACTURE 1 0.0000
364 CHOLELITHIASIS 1 0.0000
365 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
366 LIP SWELLING 1 0.0000
367 GAIT INABILITY 1 0.0000
368 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
369 DRUG INEFFECTIVE 39 0.0000
370 URINARY TRACT INFECTION 5 0.0000
371 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
372 RASH MACULAR 1 0.0000
373 COUGH 8 0.0000
374 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
375 CEREBRAL HAEMORRHAGE 1 0.0000
376 SKIN BURNING SENSATION 2 0.0000
377 FALL 9 0.0000
378 BRONCHITIS 2 0.0000
379 EPISTAXIS 2 0.0000
380 ASTHMA 3 0.0000
381 MUSCULAR WEAKNESS 3 0.0000
382 DIABETES MELLITUS 2 0.0000
383 INJECTION SITE SWELLING 2 0.0000
384 WEIGHT DECREASED 7 0.0000
385 EXTRA DOSE ADMINISTERED 1 0.0000
386 DEVICE BREAKAGE 1 0.0000
387 ERYTHEMA 5 0.0000
388 OSTEOPOROSIS 1 0.0000
389 TREATMENT FAILURE 2 0.0000
390 POLLAKIURIA 1 0.0000
391 CEREBROVASCULAR ACCIDENT 4 0.0000
392 RECTAL HAEMORRHAGE 1 0.0000
393 DRY SKIN 3 0.0000
394 THROAT IRRITATION 1 0.0000
395 THERAPY NON-RESPONDER 1 0.0000
396 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
397 SKIN IRRITATION 1 0.0000
398 NEPHROLITHIASIS 1 0.0000
399 TINNITUS 1 0.0000
400 SKIN DISCOLOURATION 1 0.0000
401 COGNITIVE DISORDER 1 0.0000
402 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
403 PRODUCT USE ISSUE 4 0.0000
404 ARRHYTHMIA 1 0.0000
405 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
406 INTERSTITIAL LUNG DISEASE 1 0.0000
407 LEUKOPENIA 1 0.0000
408 BLOOD PRESSURE INCREASED 3 0.0000
409 CHEST DISCOMFORT 2 0.0000
410 SINUSITIS 2 0.0000
411 THERAPY CESSATION 1 0.0000
412 INFLAMMATION 1 0.0000
413 ECZEMA 1 0.0000
414 DERMATITIS ATOPIC 1 0.0000
415 FLATULENCE 1 0.0000
416 ANXIETY 5 0.0000
417 HERPES ZOSTER 1 0.0000
418 BONE PAIN 1 0.0000
419 NASAL CONGESTION 1 0.0000
420 IRRITABILITY 1 0.0000
421 STOMATITIS 1 0.0000
422 NASOPHARYNGITIS 3 0.0000
423 PRODUCT DOSE OMISSION 1 0.0000
424 INSOMNIA 4 0.0000
425 INJECTION SITE PRURITUS 1 0.0000
426 INJURY 1 0.0000
427 HYPERTENSION 3 0.0000
428 DIZZINESS 7 0.0000
429 MOBILITY DECREASED 1 0.0000
430 UNDERDOSE 1 0.0000
431 CONDITION AGGRAVATED 4 0.0000
432 PRURITUS 5 0.0000
433 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
434 DRY MOUTH 1 0.0000
435 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
436 TREMOR 2 0.0000
437 ABDOMINAL DISCOMFORT 2 0.0000
438 SKIN EXFOLIATION 1 0.0000
439 MYOCARDIAL INFARCTION 2 0.0000
440 GASTROINTESTINAL DISORDER 1 0.0000
441 DEVICE ISSUE 1 0.0000
442 SUICIDAL IDEATION 1 0.0000
443 MUSCLE SPASMS 2 0.0000
444 ADVERSE EVENT 1 0.0000
445 BREAST CANCER 1 0.0000
446 CARDIAC DISORDER 1 0.0000
447 SWELLING 1 0.0000
448 DYSPHAGIA 1 0.0000
449 GAIT DISTURBANCE 2 0.0000
450 CONTUSION 1 0.0000
451 DRUG INTOLERANCE 1 0.0000
452 ALOPECIA 2 0.0000
453 DYSPEPSIA 1 0.0000
454 SYNCOPE 1 0.0000
455 FLUSHING 1 0.0000
456 PAIN 6 0.0000
457 HAEMOGLOBIN DECREASED 1 0.0000
458 ARTHRALGIA 4 0.0000
459 HAEMORRHAGE 1 0.0000
460 PNEUMONIA 3 0.0000
461 CONSTIPATION 2 0.0000
462 INFLUENZA 1 0.0000
463 SEPSIS 1 0.0000
464 DYSPNOEA 5 0.0000
465 RHEUMATOID ARTHRITIS 1 0.0000
466 DEPRESSION 2 0.0000
467 INCORRECT DOSE ADMINISTERED 2 0.0000
468 ABDOMINAL PAIN 2 0.0000
469 PALPITATIONS 1 0.0000
470 DISEASE PROGRESSION 1 0.0000
471 FEELING ABNORMAL 2 0.0000
472 EMOTIONAL DISTRESS 1 0.0000
473 INJECTION SITE ERYTHEMA 1 0.0000
474 ASTHENIA 3 0.0000
475 MEMORY IMPAIRMENT 1 0.0000
476 PAIN IN EXTREMITY 2 0.0000
477 HOSPITALISATION 1 0.0000
478 FATIGUE 5 0.0000
479 DRUG INTERACTION 1 0.0000
480 DIARRHOEA 4 0.0000
481 NAUSEA 4 0.0000
482 SOMNOLENCE 1 0.0000
483 ABDOMINAL PAIN UPPER 1 0.0000
484 MALAISE 2 0.0000
485 WEIGHT INCREASED 1 0.0000
486 DECREASED APPETITE 1 0.0000
487 BACK PAIN 1 0.0000
488 INJECTION SITE PAIN 1 0.0000
489 DEATH 1 0.0000